These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28384305)

  • 1. Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma.
    Anders F; Teister J; Liu A; Funke S; Grus FH; Thanos S; von Pein HD; Pfeiffer N; Prokosch V
    PLoS One; 2017; 12(4):e0175451. PubMed ID: 28384305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Crystallin Expression and RGC Susceptibility in Experimental Glaucoma Rats of Different Ages.
    Anders F; Mann C; Liu A; Teister J; Funke S; Thanos S; Grus F; Pfeiffer N; Prokosch V
    Curr Eye Res; 2018 Oct; 43(10):1267-1273. PubMed ID: 29979889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model.
    Anders F; Liu A; Mann C; Teister J; Lauzi J; Thanos S; Grus FH; Pfeiffer N; Prokosch V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
    Liu H; Anders F; Thanos S; Mann C; Liu A; Grus FH; Pfeiffer N; Prokosch-Willing V
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5129-5141. PubMed ID: 28986598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model.
    Anders F; Teister J; Funke S; Pfeiffer N; Grus F; Solon T; Prokosch V
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1395-1407. PubMed ID: 28536832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
    Yang H; Hirooka K; Fukuda K; Shiraga F
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.
    Tsai JC; Wu L; Worgul B; Forbes M; Cao J
    Curr Eye Res; 2005 Nov; 30(11):1025-31. PubMed ID: 16282136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
    Urcola JH; Hernández M; Vecino E
    Exp Eye Res; 2006 Aug; 83(2):429-37. PubMed ID: 16682027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury.
    Russo R; Adornetto A; Cavaliere F; Varano GP; Rusciano D; Morrone LA; Corasaniti MT; Bagetta G; Nucci C
    Mol Vis; 2015; 21():718-29. PubMed ID: 26167113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model.
    Teister J; Anders F; Beck S; Funke S; von Pein H; Prokosch V; Pfeiffer N; Grus F
    Sci Rep; 2017 Jul; 7(1):6260. PubMed ID: 28740252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.
    Prokosch V; Schallenberg M; Thanos S
    PLoS One; 2013; 8(2):e49730. PubMed ID: 23468831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions.
    Huang Y; Cen LP; Choy KW; van Rooijen N; Wang N; Pang CP; Cui Q
    Exp Eye Res; 2007 Nov; 85(5):684-95. PubMed ID: 17869246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
    Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
    Mittag TW; Danias J; Pohorenec G; Yuan HM; Burakgazi E; Chalmers-Redman R; Podos SM; Tatton WG
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3451-9. PubMed ID: 11006238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma.
    Lauzi J; Anders F; Liu H; Pfeiffer N; Grus F; Thanos S; Arnhold S; Prokosch V
    PLoS One; 2019; 14(1):e0207190. PubMed ID: 30673694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure.
    Kanamori A; Nakamura M; Mukuno H; Maeda H; Negi A
    Curr Eye Res; 2004 Jan; 28(1):47-54. PubMed ID: 14704913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.
    Danias J; Shen F; Kavalarakis M; Chen B; Goldblum D; Lee K; Zamora MF; Su Y; Brodie SE; Podos SM; Mittag T
    Exp Eye Res; 2006 Feb; 82(2):219-28. PubMed ID: 16109406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
    Naskar R; Wissing M; Thanos S
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.